Long-term outcome of antidepressant-refractory depression: The relevance of unrecognized bipolarity

Journal of Affective Disorders

Volumn 95, Issue 1-3, 2006, Pages 61-67

  Inoue, Takeshi ^a   Nakagawa, Shin ^a   Kitaichi, Yuji ^a   Izumi, Takeshi ^a   Tanaka, Teruaki ^a   Masui, Takuya ^a   Kusumi, Ichiro ^a   Denda, Kenzo ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antidepressant refractory depression; Antidepressant resistant depression; Augmentation therapy; Dopamine receptor agonist; Lithium; Mood disorder

Indexed keywords

ANTIDEPRESSANT AGENT; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; IMIPRAMINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NORADRENALIN UPTAKE INHIBITOR; PERGOLIDE; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; THYROID HORMONE; THYROXINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BIPOLAR DEPRESSION; CHRONIC DISEASE; CLINICAL ARTICLE; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR DEPRESSION; MALE; NATURALISTIC INQUIRY; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SAMPLE SIZE; SOCIAL STATUS; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 33846221561     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.04.020     Document Type: Article

References (21)

1. Akiskal H.S., Maser J.D., Zeller P.J., Endicott J., Coryell W., Keller M., Warshaw M., Clayton P., and Goodwin F. Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch. Gen. Psychiatry 52 (1995) 114-123
2. Aronson R., Offman H.J., Joffe R.T., and Naylor C.D. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch. Gen. Psychiatry 53 (1996) 842-848
3. Bauer M., and Döpfmer S. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J. Clin. Psychopharmacol. 19 (1999) 427-434
4. Bauer M., Hellweg R., Gräf K.-J., and Baumgartner A. Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology 18 (1998) 444-455
5. Halpern J.K., and Glassman A.H. Adequate tricyclic treatment: defining the tricyclic nonresponder. In: Roose S.P., and Glassman A.H. (Eds). Treatment Strategies for Refractory Depression (1990), American Psychiatric Press, Washington, DC 11-32
6. Inoue T., Izumi T., Honma Y., Ohmori T., Denda K., Kasahara T., and Koyama T. Survey and treatment strategy of antidepressant-resistant depression. Psychiatr. Neurol. Jpn. 98 (1996) 329-342 (in Japanese)
7. Inoue T., Tsuchiya K., Miura J., Sakakibara S., Denda K., Kasahara T., and Koyama T. Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression. Biol. Psychiatry 40 (1996) 151-153
8. Inoue T., Izumi T., and Koyama T. Strategy of augmentation therapy for refractory depression. In: Okuma T., Inoue Y., and Kanba S. (Eds). Recent Advances in the Research of Affective Disorders in Japan (2002), Elsevier Science, Amsterdam 147-151
9. Janicak P.G., Davis J.M., and Preskorn S.H. Principles and Practice of Psychopharmacotherapy. 3rd ed (2002), Lippincott Williams and Wilkins, Philadelphia
10. Kraepelin E. Psychiatrie. Ein Lehrbuch für Stuierende and Årzte, achten Auflage (1913), Johann Amrosius Barth, Leipzig
11. Lam R.W., Wan D.D., Cohen N.L., and Kennedy S.H. Combining antidepressants for treatment-resistant depression: a review. J. Clin. Psychiatry 63 (2002) 685-693
12. Lecrubier Y. How do you define remission?. Acta Psychatr. Scand. 106 Suppl. 415 (2002) 7-11
13. Lenderking W.R., Tennen H., Nackley J.F., Hale M.S., Turner R.R., and Testa M.A. The effects of venlafaxine on social activity level in depressed outpatients. J. Clin. Psychiatry 60 (1999) 157-163
14. Möller H.J. Therapieresistenz auf Antidepressiva: Riskfaktoren und Behandlungsmoglichkeiten. Nervenarzt 62 (1991) 658-669
15. National Institute of Mental Health. Specific feature: rating scales and assessment instruments for use in pediatric pharmacology research. Psychopharmacol. Bull. 21 4 (1985)
16. Roose S.P. Methodological issues in the diagnosis, treatment, and study of refractory depression. In: Roose S.P., and Glassman A.H. (Eds). Treatment Strategies for Refractory Depression (1990), American Psychiatric Press, Washington, DC 3-9
17. Roose S.P., Glassman A.H., Walsh B.T., and Woodring S. Tricyclic nonresponders: phenomenology and treatment. Am. J. Psychiatry 143 (1986) 345-348
18. Sharma V., Khan M., and Smith A. A closer look at treatment resistant depression: is it due to a bipolar diathesis?. J. Affect. Disord. 84 (2005) 251-257
19. Stimpson N., Agrawal N., and Lewis G. Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression: systematic review. Br. J. Psychiatry 181 (2002) 284-294
20. Thase M.E., and Rush A.J. Treatment-resistant depression. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: The Fourth Generation of Progress (1995), Raven Press, New York 1081-1097
21. Weitbrecht H.J. Psychiatrie im Grundriss, dritte Auflage (1973), Springer-Verlag, Berlin-Heidelberg-New York